Analyst Ratings for Moderna (MRNA)
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $180.00 (Argus)
- Lowest: $17.00 (Leerink)
- Average: $86.56
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$86.56 (-60.3%)
* Over Last 12-Mos
Rating Score: 2.3 / 10
Percentile Rank: 17%
Avg. $ Target:
$86.56 (-60.3%)
* Over Last 12-Mos
Rating Score: 2.3 / 10
Percentile Rank: 17%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/30/2026 | Citi | Geoff Meacham | Downgrade | Sell (Neutral) |
80.00 (60.00) |
203.46 (218.01) |
7.15% | Details |
| 9/3/2026 | Rothschild Redburn | Simon Baker | Downgrade | Sell (Neutral) |
81.00 (40.00) |
154.27 (218.01) |
41.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
